July 19, 2023 July 19, 2023Categories New TrialsNow Enrolling: The DIRECT study is testing how well FDG-PET/CT imaging can predict if treatment is working prior to surgery for patients with HER2-positive breast cancerThis study is for patients who have untreated, early-stage HER2-positive breast cancer
